Novel targets for development of drugs for treating schizophrenia: focus on glycine, D-serine and nitric oxide
K Dhami, M MacKay, JP Maia-de-Oliveira… - … Bülteni-Bulletin of …, 2013 - Taylor & Francis
… Therefore, a better approach is required to stimulate synaptic NMDA receptors to provide …
inhibition of the glycine transporter-1 (GlyT1), a transporter responsible for the removal of …
inhibition of the glycine transporter-1 (GlyT1), a transporter responsible for the removal of …
Reversible inhibition of the glycine transporter GlyT2 circumvents acute toxicity while preserving efficacy in the treatment of pain
A Mingorance‐Le Meur, P Ghisdal… - British journal of …, 2013 - Wiley Online Library
… Restoring the inhibitory tone therefore appears as a reasonable therapeutic approach for …
and glycine transporter selectivity of Org-25543 and ALX-1393 by measuring [ 3 H]glycine …
and glycine transporter selectivity of Org-25543 and ALX-1393 by measuring [ 3 H]glycine …
Efficacy of a glycine transporter 1 inhibitor TASP0315003 in animal models of cognitive dysfunction and negative symptoms of schizophrenia
S Chaki, T Shimazaki, J Karasawa, T Aoki, A Kaku… - …, 2015 - Springer
… direct stimulation of glycine modulatory sites, an increase in synaptic glycine levels through
the inhibition of glycine transporter 1 (GlyT1) might also be an effective approach. Indeed, …
the inhibition of glycine transporter 1 (GlyT1) might also be an effective approach. Indeed, …
Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia
TS Surti, M Ranganathan, JK Johannesen… - Schizophrenia …, 2023 - Elsevier
… We hypothesized that enhancing NMDAR function by inhibiting the glycine transporter-1 (GLYT1)
would improve neuroplasticity and thereby augment benefits of non-pharmacological …
would improve neuroplasticity and thereby augment benefits of non-pharmacological …
The x cystine/glutamate antiporter: A potential target for therapy of cancer and other diseases
M Lo, YZ Wang, PW Gout - Journal of cellular physiology, 2008 - Wiley Online Library
… evident that the x transporter plays an important … x transporter also plays a role in certain
CNS and eye diseases. This review focuses on the expression and function of the x transporter …
CNS and eye diseases. This review focuses on the expression and function of the x transporter …
Design and synthesis of novel and selective glycine transporter-1 (GlyT1) inhibitors with memory enhancing properties
VJ Santora, TA Almos, R Barido… - Journal of Medicinal …, 2018 - ACS Publications
… Synaptic concentrations of glycine are regulated by two sodium-dependent glycine … maintain
low extracellular glycine concentrations by removing it from synapses via transport into glial …
low extracellular glycine concentrations by removing it from synapses via transport into glial …
a Investigation of glycine transporter GLYT1 in tumour cell proliferation
C Garcia Bierhals - 2018 - theses.ncl.ac.uk
… glycine transporter, GLYT1, in supporting tumour cell proliferation utilising molecular and
pharmacological approaches. … mRNA of other amino acid transporters able to transport glycine, …
pharmacological approaches. … mRNA of other amino acid transporters able to transport glycine, …
Slc6a14 and Slc38a5 drive the glutaminolysis and serine–Glycine–One-Carbon pathways in cancer
T Sniegowski, K Korac, YD Bhutia, V Ganapathy - Pharmaceuticals, 2021 - mdpi.com
… therapy is just beginning to be recognized. If successful, this would represent a novel, hitherto
unexplored, therapeutic approach … their transport function has potential for cancer therapy. …
unexplored, therapeutic approach … their transport function has potential for cancer therapy. …
Oncology therapeutics targeting the metabolism of amino acids
… acid metabolism and promising therapeutic approaches. … the transport of multiple amino
acids and enable transport … one nitrogen from glycine, (2) the formylation of the glycine amino-…
acids and enable transport … one nitrogen from glycine, (2) the formylation of the glycine amino-…
Discovery of novel aminotetralines and aminochromanes as selective and competitive glycine transporter 1 (GlyT1) inhibitors
W Amberg, UEW Lange, M Ochse… - Journal of Medicinal …, 2018 - ACS Publications
The glycine transporter 1 (GlyT1) has emerged as a key novel target for the treatment of
schizophrenia. Herein, we report the synthesis and biological evaluation of aminotetralines and …
schizophrenia. Herein, we report the synthesis and biological evaluation of aminotetralines and …